# Abatacept Post-marketing Clinical Study in Japan

> **NCT01758198** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 405 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Abatacept
- **DRUG:** Placebo matching with Abatacept
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT01758198
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-11
- **Primary completion:** 2016-12-26
- **Final completion:** 2016-12-26
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758198, "Abatacept Post-marketing Clinical Study in Japan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01758198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*